Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Larimar Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 54 | 49 | −5 |
| Shares | 14.5M | 14.6M | +47.8K (+0.3%) |
| Value | $167.5M | $157.2M | −$10.3M (−6.2%) |
New holders (5)
Institutions that held Larimar Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mangrove Partners | 239,953 | $2.59M | 0.19% |
| Bridgeway Capital Management, LLC | 62,800 | $678.0K | 0.01% |
| Difesa Capital Management, LP | 52,450 | $566.0K | 0.41% |
| Golden State Equity Partners | 25,015 | $270.0K | 0.14% |
| Cutler Group LP | 1,200 | $12.0K | 0.00% |
Sold out (10)
Institutions that held Larimar Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 309,260 | $3.57M |
| BIT Capital GmbH | 94,016 | $1.08M |
| Asymmetry Capital Management, L.P. | 34,943 | $403.0K |
| Belvedere Trading LLC | 22,954 | $276.0K |
| HRT Financial LP | 21,174 | $244.0K |
| Goldman Sachs Group Inc | 13,053 | $151.0K |
| Jane Street Group, LLC | 12,001 | $138.0K |
| Group One Trading, L.P. | 1,000 | $12.0K |
| Cubist Systematic Strategies, LLC | 793 | $9.00K |
| Penserra Capital Management LLC | 405 | $4.00K |